메뉴 건너뛰기
British Journal of Clinical Pharmacology
Volumn 58, Issue 1, 2004, Pages 1-3
What is a clinical trial?
Author keywords

[No Author keywords available]
Indexed keywords

DRUG; MONOAMINE OXIDASE INHIBITOR; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR;
EID: 3142590633     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02184.x     Document Type: Editorial
Times cited : (15)
References (8)
  • 1
    • 0003177157 scopus 로고    scopus 로고
    • Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
    • 1 May
    • The European Parliament and the Council of the European Union. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. EN Official Journal of the European Communities 2001, 1 May: L 121/34.
    • (2001) EN Official Journal of the European Communities , vol.L 121 , Issue.34
  • 2
    • 3142561005 scopus 로고    scopus 로고
    • http://www.europa.eu.int/eur-lex/en/search/search_lif.html (Accessed 27 May 2004).
  • 3
    • 0027264006 scopus 로고
    • Evidence for an altered mode of action of the sodium/lithium countertransporter in vivo in patients with untreated essential hypertension
    • Brearley CJ, Wood AJ, Aronson JK, Grahame-Smith DG. Evidence for an altered mode of action of the sodium/lithium countertransporter in vivo in patients with untreated essential hypertension. J Hypertens 1993; 11: 147-53.
    • (1993) J Hypertens , vol.11 , pp. 147-153
    • Brearley, C.J.1    Wood, A.J.2    Aronson, J.K.3    Grahame-Smith, D.G.4
  • 4
    • 0345689707 scopus 로고    scopus 로고
    • A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine
    • Medawar C, Herxheimer A. A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med 2003/ 2004; 16: 5-19.
    • (2003) Int J Risk Saf Med , vol.16 , pp. 5-19
    • Medawar, C.1    Herxheimer, A.2
  • 5
    • 0019203891 scopus 로고
    • Monoamine oxidase inhibitors: Prescription and patient management
    • Sheehan DV, Claycomb JB, Kouretas N. Monoamine oxidase inhibitors: prescription and patient management. Int J Psychiatry Med 1980-81; 10: 99-121.
    • (1980) Int J Psychiatry Med , vol.10 , pp. 99-121
    • Sheehan, D.V.1    Claycomb, J.B.2    Kouretas, N.3
  • 7
    • 0035901579 scopus 로고    scopus 로고
    • The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
    • CONSORT Group (Consolidated Standards of Reporting Trials)
    • Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T. CONSORT Group (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-94.
    • (2001) Ann Intern Med , vol.134 , pp. 663-694
    • Altman, D.G.1    Schulz, K.F.2    Moher, D.3    Egger, M.4    Davidoff, F.5    Elbourne, D.6    Gotzsche, P.C.7    Lang, T.8
  • 8
    • 3142622448 scopus 로고    scopus 로고
    • CONSORT http://www.consort-statement.org (Accessed 27 May 2004).

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.